FDA Inspection
Allergan Pharmaceuticals IrelandAllergan Pharmaceuticals Ireland – FDA Inspection, Dec 16, 2016
Record Details
This FDA Inspection record concerns Allergan Pharmaceuticals Ireland, with an inspection on December 16, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · f70e2599-43b0-412f-9cc1-6790f219ec6f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1002463
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.192Quality control unit review of records
- 21 CFR 211.42(c)(10)(iii)Air Supply
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Allergan Pharmaceuticals Ireland
8| Date | Classification | Office | Project area |
|---|---|---|---|
| January 30, 2025 | Not classified | Office of Inspections and Investigations | |
| June 17, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 4, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 3, 2015 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| July 11, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Allergan Pharmaceuticals Ireland
- FDA Inspection 1259046 - 2025-01-30
- FDA Inspection 1194596 - 2022-06-17
- FDA Inspection 1117366 - 2018-05-04
- FDA Inspection 933338 - 2015-07-03
- FDA Inspection 842267 - 2013-07-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.